MarketPeel
Insider Trading Intelligence
Pricing
…
JR

Jamie L. Reynoso

CLOV
CEO, MEDICARE ADVANTAGE · CLOVER HEALTH INVESTMENTS, CORP. /DE · CIK 0001839066
FILING MIX · LIFETIME18%/82%
BUYS
16
SELLS
73
TOTAL VALUE
$3.80M
COMPANIES
1
ACTIVE SINCE
Jan 2021
HOLDINGS NOW
2,832,598
AVG SELL PX
$2.68
TRADE KIND
SHOWING 89 / 89
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
12 backtested trades · 8 horizons · 23 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Jamie L. Reynoso, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d12+41.67%+2.42%+0.79%+1.63%+0.97%—
14d12+58.33%-1.34%+0.85%-2.19%-7.42%—
30d12+75.00%-7.20%+1.81%-9.02%-11.07%—
60d12+83.33%-5.13%+2.87%-8.00%-15.07%—
90d12+66.67%+4.95%+4.92%+0.03%-12.25%—
180d12(2 pending)+80.00%+2.89%+7.47%-4.58%-26.35%—
1y12(9 pending)+0.00%+87.34%+21.90%+65.44%+60.97%—
2y12(12 pending)——————
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CLOV · 2,832,598 shares · as of Jul 8, 2026
0867,9631,735,9272,603,8903,471,85320222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 16 buys / 73 sellsCOVERAGE · 23 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE10b5-1
10b5-1 plan
2,384$4.68$11.2K2,832,598Jul 8, 2026Jul 9, 2026 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE10b5-1
10b5-1 plan
6,229$5.26$32.8K2,834,982Jul 6, 2026Jul 6, 2026 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE10b5-1
10b5-1 plan
2,360$4.78$11.3K2,841,211Jun 17, 2026Jun 18, 2026 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE10b5-1
10b5-1 plan
6,350$4.61$29.3K2,843,571Jun 15, 2026Jun 16, 2026 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE10b5-1
10b5-1 plan
7,289$4.91$35.8K2,849,921Jun 11, 2026Jun 11, 2026 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
12,712$2.04$25.9K2,857,210Apr 15, 2026Apr 16, 2026 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
6,197$1.72$10.7K2,869,922Apr 3, 2026Apr 7, 2026 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
PURCHASEGRANT
Stock grant
159,384——2,876,119Apr 1, 2026Apr 3, 2026 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE10b5-1
10b5-1 plan
5,833$1.91$11.1K2,716,735Mar 18, 2026Mar 18, 2026 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
6,187$1.98$12.3K2,722,568Mar 15, 2026Mar 17, 2026 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
8,945$1.98$17.7K2,728,755Mar 14, 2026Mar 17, 2026 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE10b5-1
10b5-1 plan
4,597$2.58$11.9K2,737,700Jan 20, 2026Jan 20, 2026 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
14,732$2.81$41.4K2,742,297Jan 15, 2026Jan 20, 2026 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE10b5-1
10b5-1 plan
2,102$2.53$5.3K2,757,029Jan 7, 2026Jan 7, 2026 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
8,109$2.41$19.5K2,759,131Jan 3, 2026Jan 5, 2026 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE10b5-1
10b5-1 plan
4,913$2.61$12.8K2,767,240Dec 18, 2025Dec 18, 2025 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
8,691$2.70$23.5K2,772,153Dec 15, 2025Dec 16, 2025 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
12,567$2.70$33.9K2,780,844Dec 14, 2025Dec 16, 2025 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE10b5-1
10b5-1 plan
30,385$3.58$108.8K2,793,411Nov 4, 2025Nov 5, 2025 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
101,917$3.53$359.8K2,853,309Oct 31, 2025Nov 4, 2025 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
29,513$3.53$104.2K2,823,796Oct 31, 2025Nov 4, 2025 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE10b5-1
10b5-1 plan
16,514$2.69$44.4K2,955,226Oct 17, 2025Oct 21, 2025 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
71,432$2.80$200.0K2,971,740Oct 15, 2025Oct 17, 2025 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE10b5-1
10b5-1 plan
2,012$2.65$5.3K3,043,172Oct 7, 2025Oct 7, 2025 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
8,706$2.59$22.5K3,045,184Oct 3, 2025Oct 7, 2025 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE10b5-1
10b5-1 plan
4,914$3.09$15.2K3,053,890Sep 17, 2025Sep 19, 2025 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
8,691$3.14$27.3K3,058,804Sep 15, 2025Sep 16, 2025 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
12,567$3.06$38.5K3,067,495Sep 14, 2025Sep 16, 2025 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE10b5-1
10b5-1 plan
6,823$2.89$19.7K3,261,485Aug 4, 2025Aug 6, 2025 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
29,513$2.89$85.3K3,268,308Jul 31, 2025Aug 4, 2025 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE10b5-1
10b5-1 plan
2,012$2.85$5.7K3,297,821Jul 7, 2025Jul 8, 2025 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE10b5-1
10b5-1 plan
19,789$2.58$51.1K3,308,539Jul 3, 2025Jul 8, 2025 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
8,706$2.56$22.3K3,299,833Jul 3, 2025Jul 8, 2025 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
PURCHASEGRANT
Stock grant
217,523——3,413,924Jun 30, 2025Jul 2, 2025 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
85,596$2.79$238.8K3,328,328Jun 30, 2025Jul 2, 2025 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
85,596$2.79$238.8K2,887,905Jun 30, 2025Sep 16, 2025 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE10b5-1
10b5-1 plan
20,450$2.86$58.5K3,196,401Jun 17, 2025Jun 18, 2025 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
8,691$2.89$25.1K3,216,851Jun 15, 2025Jun 17, 2025 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
12,567$2.89$36.3K3,225,542Jun 14, 2025Jun 17, 2025 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
25,659$3.40$87.2K3,238,109Apr 30, 2025May 2, 2025 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
6,366$3.51$22.3K3,263,768Apr 3, 2025Apr 7, 2025 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
6,354$3.66$23.3K3,270,134Mar 15, 2025Mar 18, 2025 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
9,188$3.66$33.6K3,276,488Mar 14, 2025Mar 18, 2025 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
21,578$4.39$94.7K3,285,676Jan 31, 2025Feb 4, 2025 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
17,142$3.60$61.7K3,307,254Jan 7, 2025Jan 10, 2025 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
8,149$3.29$26.8K3,324,396Jan 3, 2025Jan 7, 2025 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
8,691$3.11$27.0K3,332,545Dec 15, 2024Dec 17, 2024 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
12,567$3.11$39.1K3,341,236Dec 14, 2024Dec 17, 2024 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
118,050$4.12$486.4K3,353,803Oct 31, 2024Nov 4, 2024 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
PURCHASEGRANT
Stock grant
726,114——3,471,853Oct 15, 2024Oct 17, 2024 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
8,706$4.00$34.8K2,745,739Oct 3, 2024Oct 7, 2024 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
8,691$2.99$26.0K2,754,445Sep 15, 2024Sep 17, 2024 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
12,567$2.99$37.6K2,763,136Sep 14, 2024Sep 17, 2024 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
PURCHASEGRANT
Stock grant
518,000——2,531,545Sep 13, 2024Sep 16, 2025 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
PURCHASEGRANT
Stock grant
259,000——2,877,620Sep 13, 2024Sep 17, 2024 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
101,917$2.99$304.7K2,775,703Sep 13, 2024Sep 17, 2024 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
5,388$1.25$6.7K2,618,620Jul 3, 2024Jul 8, 2024 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
52,967$1.23$65.1K2,401,108Jun 30, 2024Sep 16, 2025 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
52,967$1.23$65.1K2,624,008Jun 30, 2024Jul 2, 2024 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
PURCHASEGRANT
Stock grant
217,522——2,676,975Jun 30, 2024Jul 2, 2024 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
5,378$1.09$5.9K2,454,075Jun 15, 2024Jun 18, 2024 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
7,776$1.09$8.5K2,459,453Jun 14, 2024Jun 18, 2024 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
5,387$0.76$4.1K2,467,229Apr 3, 2024Apr 5, 2024 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
5,378$0.80$4.3K2,472,616Mar 15, 2024Mar 19, 2024 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
7,777$0.73$5.7K2,477,994Mar 14, 2024Mar 18, 2024 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
16,369$0.95$15.6K2,485,771Jan 7, 2024Jan 9, 2024 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
26,240$0.92$24.1K2,502,140Jan 3, 2024Jan 5, 2024 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
1,559$0.95$1.5K2,528,380Jan 1, 2024Jan 3, 2024 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO, Medicare Advantage
8,691$0.99$8.6K2,529,825Dec 15, 2023Dec 19, 2023 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
Chief Operating Officer
12,567$1.00$12.6K2,538,516Dec 14, 2023Dec 18, 2023 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
PURCHASEGRANT
Stock grant
600,000——2,551,083Oct 31, 2023Nov 2, 2023 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO of Medicare Advantage
21,511$1.13$24.3K1,951,083Sep 15, 2023Sep 18, 2023 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO of Medicare Advantage
7,776$1.13$8.8K1,972,594Sep 14, 2023Sep 18, 2023 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
PURCHASEGRANT
Stock grant
652,566——2,033,451Sep 7, 2023Jan 3, 2024 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO of Medicare Advantage
52,967$1.31$69.4K1,980,370Sep 7, 2023Sep 11, 2023 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
PURCHASEGRANT
Stock grant
652,452——2,033,337Sep 7, 2023Sep 11, 2023 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO of Medicare Advantage
7,776$0.94$7.3K1,380,885Jun 14, 2023Jun 16, 2023 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO of Medicare Advantage
31,455$0.93$29.3K1,388,661Mar 14, 2023Apr 26, 2023 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO of Medicare Advantage
1,281$1.33$1.7K1,420,116Jan 31, 2023Apr 26, 2023 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO of Medicare Advantage
16,369$1.01$16.5K1,421,397Jan 7, 2023Apr 26, 2023 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
PURCHASEGRANT
Stock grant
353,982——1,454,877Jan 3, 2023Jan 4, 2023 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
PURCHASEGRANT
Stock grant
353,356——1,100,895Sep 16, 2022Sep 20, 2022 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
PURCHASEGRANT
Stock grant
510,948——747,539Mar 14, 2022Mar 16, 2022 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO of Medicare Advantage
1,281$2.58$3.3K235,310Jan 31, 2022Apr 26, 2023 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
PURCHASEGRANT
Stock grant
15,771——236,591Jan 31, 2022Feb 2, 2022 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SALE
CEO of Medicare Advantage
15,830$3.16$50.0K1,437,766Jan 7, 2022Apr 26, 2023 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
PURCHASEGRANT
Stock grant
220,820——220,820Jul 16, 2021Jul 20, 2021 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
PURCHASEGRANT
Stock grant
465,316——465,316Jan 7, 2021Jan 11, 2021 ↗View →
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
PURCHASEGRANT
Stock grant
51,701——51,701Jan 7, 2021Jan 11, 2021 ↗View →
Other insiders · CLOV
Loading peer insiders…
About this filer
CIK 0001839066
ROLE
CEO, Medicare Advantage
PRIMARY
CLOV
COMPANIES
1
ACTIVE SINCE
Jan 2021
MARKETPEEL · /INSIDER/0001839066DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback